Literature DB >> 35673341

Time Management in Chronic Total Occlusion Percutaneous Coronary Interventions: When Do We Need to Change the Crossing Strategy?

Dmitrii Khelimskii1, Aram Badoian1, Aleksey Baranov1, Oleg Krestyaninov1, Dmitrii Ponomarev1.   

Abstract

Background: Most complex chronic total occlusions (CTOs) require the utilization of multiple recanalization strategies. However, data on wire manipulation time within CTO percutaneous coronary intervention (PCI) are limited.
Objectives: We sought to investigate the impact of crossover time between crossing strategies on CTO PCI technical success.
Methods: A total of 1026 patients admitted to our center between 2013 and 2019 for CTO PCI were assessed, of whom 143 were included for analysis. In these patients, the primary antegrade approach was changed to retrograde within one procedure. The crossover time between strategies remained at the operator's decision.
Results: In most cases the target vessel was the right coronary artery (72%), followed by the left anterior descending (18.2%) and left circumflex (9.1%) arteries. The mean J-CTO score was 2.1 ± 1.1. Logistic regression analysis was used to estimate the odds of technical success associated with various crossover times. The results showed that 33 minutes was the threshold of the initial timing at which to review crossover of antegrade to retrograde recanalization of CTO. The odds of technical success with earlier crossover were 3.4 times higher [95% confidence interval (CI): 1.3 to 8.6]. The chances of success reduced by 3% for every 1 minute longer than the threshold time (odds ratio: 0.97; 95% CI: 0.94 to 0.99, p = 0.05). Conclusions: Crossover to the retrograde approach should be considered no later than 33 minutes after antegrade wire manipulation in order to maintain the maximum chances of final technical success.

Entities:  

Keywords:  Antegrade recanalization; Chronic coronary total occlusion; Crossover time; Percutaneous coronary intervention; Retrograde recanalization

Year:  2022        PMID: 35673341      PMCID: PMC9121753          DOI: 10.6515/ACS.202205_38(3).20211204A

Source DB:  PubMed          Journal:  Acta Cardiol Sin        ISSN: 1011-6842            Impact factor:   1.800


  16 in total

1.  Current perspectives on coronary chronic total occlusions: the Canadian Multicenter Chronic Total Occlusions Registry.

Authors:  Paul Fefer; Merril L Knudtson; Asim N Cheema; P Diane Galbraith; Azriel B Osherov; Sergey Yalonetsky; Sharon Gannot; Michelle Samuel; Max Weisbrod; Daniel Bierstone; John D Sparkes; Graham A Wright; Bradley H Strauss
Journal:  J Am Coll Cardiol       Date:  2012-03-13       Impact factor: 24.094

2.  Comparison of percutaneous coronary intervention for chronic total occlusion outcome according to operator experience from the Japanese retrograde summit registry.

Authors:  Maoto Habara; Etsuo Tsuchikane; Toshiya Muramatsu; Yoshifumi Kashima; Atsunori Okamura; Makoto Mutoh; Masahisa Yamane; Akitsugu Oida; Yuji Oikawa; Katsuyuki Hasegawa
Journal:  Catheter Cardiovasc Interv       Date:  2015-12-31       Impact factor: 2.692

3.  Application and outcomes of a hybrid approach to chronic total occlusion percutaneous coronary intervention in a contemporary multicenter US registry.

Authors:  Georgios Christopoulos; Dimitri Karmpaliotis; Khaldoon Alaswad; Robert W Yeh; Farouc A Jaffer; R Michael Wyman; William L Lombardi; Rohan V Menon; J Aaron Grantham; David E Kandzari; Nicholas Lembo; Jeffrey W Moses; Ajay J Kirtane; Manish Parikh; Philip Green; Matthew Finn; Santiago Garcia; Anthony Doing; Mitul Patel; John Bahadorani; Muhammad Nauman J Tarar; Georgios E Christakopoulos; Craig A Thompson; Subhash Banerjee; Emmanouil S Brilakis
Journal:  Int J Cardiol       Date:  2015-06-27       Impact factor: 4.164

4.  A Novel Algorithm for Treating Chronic Total Coronary Artery Occlusion.

Authors:  Hiroyuki Tanaka; Etsuo Tsuchikane; Toshiya Muramatsu; Koichi Kishi; Makoto Muto; Yuji Oikawa; Tomohiro Kawasaki; Yuji Hamazaki; Tsutomu Fujita; Osamu Katoh
Journal:  J Am Coll Cardiol       Date:  2019-11-12       Impact factor: 24.094

5.  Percutaneous Treatment of Coronary Chronic Total Occlusions Part 1: Rationale and Outcomes.

Authors:  Alfredo Galassi; Aaron Grantham; David Kandzari; William Lombardi; Issam Moussa; Craig Thompson; Gerald Werner; Charles Chambers; Emmanouil Brilakis
Journal:  Interv Cardiol       Date:  2014-08

6.  European experience with the retrograde approach for the recanalisation of coronary artery chronic total occlusions. A report on behalf of the euroCTO club.

Authors:  Georgios Sianos; Peter Barlis; Carlo Di Mario; Michail I Papafaklis; Joachim Büttner; Alfredo R Galassi; Joachim Schofer; Gerald Werner; Thierry Lefevre; Yves Louvard; Patrick W Serruys; Nicolaus Reifart
Journal:  EuroIntervention       Date:  2008-05       Impact factor: 6.534

7.  Prevalence and management of coronary chronic total occlusions in a tertiary Veterans Affairs hospital.

Authors:  Omar M Jeroudi; Mohammed E Alomar; Tesfaldet T Michael; Abdallah El Sabbagh; Vishal G Patel; Owen Mogabgab; Eric Fuh; Daniel Sherbet; Nathan Lo; Michele Roesle; Bavana V Rangan; Shuaib M Abdullah; Jeffrey L Hastings; Jerrold Grodin; Subhash Banerjee; Emmanouil S Brilakis
Journal:  Catheter Cardiovasc Interv       Date:  2013-11-13       Impact factor: 2.692

8.  Fourth universal definition of myocardial infarction (2018).

Authors:  Kristian Thygesen; Joseph S Alpert; Allan S Jaffe; Bernard R Chaitman; Jeroen J Bax; David A Morrow; Harvey D White
Journal:  Eur Heart J       Date:  2019-01-14       Impact factor: 29.983

Review 9.  Theory and practical based approach to chronic total occlusions.

Authors:  Georgios Sianos; Nikolaos V Konstantinidis; Carlo Di Mario; Haralambos Karvounis
Journal:  BMC Cardiovasc Disord       Date:  2016-02-09       Impact factor: 2.298

Review 10.  Chronic Total Occlusion Percutaneous Coronary Intervention: Evidence and Controversies.

Authors:  Peter Tajti; Emmanouil S Brilakis
Journal:  J Am Heart Assoc       Date:  2018-01-12       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.